Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM5A | P29375 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25218755 | 1.00 | NAAA (0.50) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL25211926 | 1.00 | NAAA (0.50) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL25198827 | 1.00 | NAAA (0.50) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL25196488 | 1.00 | NAAA (0.50) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL2119448 | 1.00 | NAAA (0.50) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL21749894 | 0.98 | NAAA (0.48) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL22345150 | 0.98 | NAAA (0.48) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL11196810 | 0.98 | NAAA (0.48) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL21383406 | 0.98 | NAAA (0.48) | NAAADNM1DGKALMNAKDM5A | |
| SCHEMBL168800 | 0.98 | NAAA (0.48) | NAAADNM1DGKALMNAKDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114269439-A | Non-fluorinated agents for liquid vehicle systems | 泰科消防产品有限合伙公司 | 2022-04-01 | — | — | CN | claimed |
| CN-108184912-A | A kind of chitosan argy wormwood oil microcapsule and preparation method thereof | 江苏华尔化工有限公司 | 2018-06-22 | — | — | CN | claimed |
| CN-105349046-A | Oil-in-water emulsified diamond grinding solution and preparation method thereof | ZHENGZHOU RES INST ABRASIVES & GRINDING CO LTD | 2016-02-24 | — | — | CN | claimed |
| CN-103710772-B | Fiber original liquid coloring superfine carbon black aqueous color paste | SUZHOU SHIMING TECHNOLOGY CO., LTD. (CN) | 2015-09-23 | — | — | CN | claimed |
| EP-1339413-B1 | Compositions comprising complexes of phosphate derivatives of tocopherol | VITAL HEALTH SCIENCES PTY LTD (AU) | 2009-10-07 | — | — | EP | claimed |
| WO-2023085009-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION AND POLISHING METHOD | JSR株式会社 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023085007-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION AND POLISHING METHOD | JSR株式会社 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023085008-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION, PRODUCTION METHOD THEREFOR, AND POLISHING METHOD | JSR株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-114269439-A | Non-fluorinated agents for liquid vehicle systems | 泰科消防产品有限合伙公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-113728109-A | Method for purifying bacterial polysaccharides | 辉瑞公司 | 2021-11-30 | — | — | CN | disclosed |
| CN-108368252-B | Substoichiometric amounts of alkoxylated polyethers | 巴斯夫欧洲公司 | 2021-02-12 | — | — | CN | disclosed |
| US-10874645-B2 | Isoxazoline-substituted benzamide compound and pesticide | NISSAN CHEMICAL CORPORATION (JP) | 2020-12-29 | — | — | US | disclosed |
| US-20100261670-A1 | COMPLEXES OF PHOSPHATE DERIVATIVES | WEST SIMON MICHAEL | 2010-10-14 | — | — | US | disclosed |
| US-20100222305-A1 | COMPLEXES OF PHOSPHATE DERIVATIVES | WEST SIMON MICHAEL | 2010-09-02 | — | — | US | disclosed |
| EP-1339413-B1 | Compositions comprising complexes of phosphate derivatives of tocopherol | VITAL HEALTH SCIENCES PTY LTD (AU) | 2009-10-07 | — | — | EP | disclosed |
| EP-1339413-A4 | COMPLEXES OF PHOSPHATE DERIVATIVES | VITAL HEALTH SCIENCES PTY LTD (AU) | 2004-12-15 | — | — | EP | disclosed |
| US-20040097472-A1 | Complexes of phosphate derivatives | VITAL HEALTH SCIENCES PTY LTD. (AU) | 2004-05-20 | — | — | US | disclosed |
| US-20040052754-A1 | Complexes of phosphate derivatives | VITAL HEALTH SCIENCES PTY LTD. (AU) | 2004-03-18 | — | — | US | disclosed |
| EP-1339413-A1 | COMPLEXES OF PHOSPHATE DERIVATIVES | Vital Health Sciences Pty Ltd. (AU) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002040034-A1 | COMPLEXES OF PHOSPHATE DERIVATIVES | VITAL HEALTH SCIENCES PTY LTD. (AU) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874645-B2 | Isoxazoline-substituted benzamide compound and pesticide | C3AR1, C5, C9 | NAAA 1978/4885DNM1 4821/4885DGKA 4321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.